PCVX insider transactions
Vaxcyte Inc. (PCVX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for PCVX
- SEC Form 4 filed by Director Markels John4 - Vaxcyte, Inc. (0001649094) (Issuer)
- New insider Markels John claimed no ownership of stock in the company (SEC Form 3)3 - Vaxcyte, Inc. (0001649094) (Issuer)
- PRESIDENT AND CFO Guggenhime Andrew exercised 10,000 shares at a strike of $5.35 and sold $572,837 worth of shares (10,000 units at $57.28) as part of a pre-agreed trading plan (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF OPERATING OFFICER Wassil Jim exercised 516 shares at a strike of $5.35 and sold $126,736 worth of shares (2,250 units at $56.33) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 156,760 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF EXECUTIVE OFFICER Pickering Grant sold $1,338,270 worth of shares (24,237 units at $55.22) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 452,466 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Director Slaoui Moncef4 - Vaxcyte, Inc. (0001649094) (Issuer)
- New insider Slaoui Moncef claimed no ownership of stock in the company (SEC Form 3)3 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF EXECUTIVE OFFICER Pickering Grant exercised 225 shares at a strike of $1.79 and sold $1,284,205 worth of shares (24,461 units at $52.50) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 474,703 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- PRESIDENT AND CFO Guggenhime Andrew exercised 10,000 shares at a strike of $5.35 and sold $530,000 worth of shares (10,000 units at $53.00) as part of a pre-agreed trading plan (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Paya Carlos V was granted 2,265 shares, increasing direct ownership by 49% to 6,856 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Brandicourt Olivier was granted 2,194 shares, increasing direct ownership by 88% to 4,699 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Furey John was granted 2,265 shares, increasing direct ownership by 74% to 5,306 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Lee Jacks was granted 2,265 shares, increasing direct ownership by 49% to 6,856 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Gilbert Halley E was granted 2,265 shares, increasing direct ownership by 22% to 12,481 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Loxam Teri was granted 2,265 shares, increasing direct ownership by 22% to 12,481 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Drapeau Anne S was granted 2,265 shares, increasing direct ownership by 22% to 12,481 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Lukatch Heath was granted 2,265 shares, increasing direct ownership by 13% to 19,481 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF OPERATING OFFICER Wassil Jim sold $111,416 worth of shares (2,250 units at $49.52) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 158,494 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF OPERATING OFFICER Wassil Jim sold $127,870 worth of shares (2,250 units at $56.83) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 160,744 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Cowan Elvia4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Wassil Jim4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Cowan Elvia4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Vaxcyte Inc.4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF EXECUTIVE OFFICER Pickering Grant covered exercise/tax liability with 3,685 shares, decreasing direct ownership by 0.74% to 496,939 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Vaxcyte Inc.4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Vaxcyte Inc.4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Vaxcyte Inc.4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SVP, Finance & CAO Cowan Elvia covered exercise/tax liability with 569 shares, was granted 10,681 shares and exercised 7,716 shares at a strike of $25.92, increasing direct ownership by 132% to 31,362 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- PRESIDENT AND CFO Guggenhime Andrew was granted 44,864 shares and covered exercise/tax liability with 1,907 shares, increasing direct ownership by 69% to 105,416 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF EXECUTIVE OFFICER Pickering Grant covered exercise/tax liability with 5,394 shares and was granted 105,110 shares, increasing direct ownership by 25% to 500,624 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Chief Technical Ops Officer Dhaliwal Harpreet S. was granted 53,409 shares and covered exercise/tax liability with 757 shares, increasing direct ownership by 220% to 76,580 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF OPERATING OFFICER Wassil Jim was granted 37,147 shares and covered exercise/tax liability with 3,807 shares, increasing direct ownership by 24% to 175,188 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF EXECUTIVE OFFICER Pickering Grant gifted 100,000 shares, decreasing direct ownership by 20% to 400,908 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- PRESIDENT AND CFO Guggenhime Andrew gifted 61,850 shares and received a gift of 61,850 shares, decreasing direct ownership by 50% to 62,459 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Brandicourt Olivier was granted 1,357 shares, increasing direct ownership by 118% to 2,505 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Chief Technical Ops Officer Dhaliwal Harpreet S. sold $454,891 worth of shares (9,743 units at $46.69), decreasing direct ownership by 29% to 23,928 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SVP, FINANCE Cowan Elvia sold $556,972 worth of shares (11,623 units at $47.92) and gifted 1,000 shares, decreasing direct ownership by 48% to 13,534 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SVP, FINANCE Cowan Elvia covered exercise/tax liability with 482 shares, decreasing direct ownership by 2% to 26,156 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Chief Technical Ops Officer Dhaliwal Harpreet S. covered exercise/tax liability with 1,204 shares, decreasing direct ownership by 3% to 33,670 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF OPERATING OFFICER Wassil Jim covered exercise/tax liability with 2,759 shares, decreasing direct ownership by 2% to 141,848 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- PRESIDENT AND CFO Guggenhime Andrew covered exercise/tax liability with 2,890 shares, decreasing direct ownership by 2% to 124,309 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF EXECUTIVE OFFICER Pickering Grant covered exercise/tax liability with 7,356 shares, decreasing direct ownership by 1% to 500,908 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SVP, FINANCE Cowan Elvia covered exercise/tax liability with 567 shares, decreasing direct ownership by 2% to 26,638 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Chief Technical Ops Officer Dhaliwal Harpreet S. covered exercise/tax liability with 1,538 shares, decreasing direct ownership by 4% to 34,874 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF OPERATING OFFICER Wassil Jim covered exercise/tax liability with 4,286 shares, decreasing direct ownership by 3% to 146,270 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- PRESIDENT AND CFO Guggenhime Andrew covered exercise/tax liability with 5,080 shares, decreasing direct ownership by 4% to 127,199 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF EXECUTIVE OFFICER Pickering Grant covered exercise/tax liability with 10,840 shares, decreasing direct ownership by 2% to 508,264 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SVP, FINANCE Cowan Elvia was granted 2,810 shares, increasing direct ownership by 12% to 27,205 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Brandicourt Olivier was granted 1,148 shares (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Gilbert Halley E was granted 3,041 shares, increasing direct ownership by 42% to 10,216 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Loxam Teri was granted 3,041 shares, increasing direct ownership by 42% to 10,216 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Lukatch Heath was granted 3,041 shares, increasing direct ownership by 21% to 17,216 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Furey John was granted 3,041 shares (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Lee Jacks was granted 3,041 shares, increasing direct ownership by 196% to 4,591 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Drapeau Anne S was granted 3,041 shares, increasing direct ownership by 42% to 10,216 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Paya Carlos V was granted 3,041 shares, increasing direct ownership by 196% to 4,591 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Director Brandicourt Olivier4 - Vaxcyte, Inc. (0001649094) (Issuer)
- New insider Brandicourt Olivier claimed no ownership of stock in the company (SEC Form 3)3 - Vaxcyte, Inc. (0001649094) (Issuer)
- New insider Dhaliwal Harpreet S. claimed ownership of 36,083 shares (SEC Form 3)3 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Lukatch Heath exercised 7,000 shares at a strike of $16.78, increasing direct ownership by 98% to 14,175 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)